Homo sapiens, the maintenance of homeostasis is dependent on the continual flow and processing of information through a complex network of cells. Moreover, in order for the organism to respond to an ever-changing environment, intercellular signals must be transduced, amplified, and ultimately converted to the appropriate physiological response. The resolution of the molecular events underlying signal response and integration forms the basis of the signal transduction field of research. An evolutionarily highly conserved group of molecules known as heterotrimeric guanine nucleotide-binding proteins (G proteins) are key determinants of the specificity and temporal characteristics of many signaling processes and are the topic of this review. Numerous hormones, neurotransmitters, chemokines, local mediators, and sensory stimuli exert their effects on cells by binding to heptahelical membrane receptors coupled to heterotrimeric G proteins. These highly specialized transducers can modulate the activity of multiple signaling pathways leading to diverse biological responses. In vivo, specific combinations of G␣-and G␤␥-subunits are likely required for connecting individual receptors to signaling pathways. The structural determinants of receptor-G protein-effector specificity are not completely understood and, in addition to involving interaction domains of these primary acting proteins, also require the participation of scaffolding and regulatory proteins. (Endocrine Reviews 24: 765-781, 2003)
I. Introduction
W HEN A LIGAND such as a hormone, neurotransmitter, or glycoprotein interacts with a heptahelical receptor on the surface of the cell, the ligand either stabilizes or induces a conformation in the receptor that activates a heterotrimeric G protein (composed of ␣-, ␤-, and ␥-subunits) on the inner membrane surface of the cell (1) . In the inactive heterotrimeric state, GDP is bound to the G␣-subunit. Upon activation, GDP is released, GTP binds to G␣, and subsequently G␣-GTP dissociates from G␤␥ and from the receptor (Fig. 1 ). Both G␣-GTP and G␤␥ are then free to activate downstream effectors. The duration of the signal is determined by the intrinsic GTP hydrolysis rate of the G␣-subunit and the subsequent reassociation of G␣-GDP with G␤␥ (1, 2) . This article will review current knowledge and recent progress in defining the molecular mechanisms that regulate the activity and specificity of G protein signaling cascades. In addition, we will briefly discuss the use of dynamic experimental approaches that are likely to provide new insights into G protein regulation in the future.
II. G Protein Structure
The solution of crystal structures for inactive (GDPbound), active (GTP-bound), and transition state (GDP-ALF 4 Ϫ ) G␣ t (3) (4) (5) or G␣ i (6) , as well as structures for the inactive heterotrimeric complexes (7, 8) , has provided the framework for understanding the biomechanics of G proteins as molecular switches. For a detailed discussion of the Abbreviations: AC, Adenylyl cyclase; AGS, activators of G protein signaling; GAP, GTPase-activating protein; GRIN, G protein-regulated inducer of neurite outgrowth; PI 3 kinase, phosphoinositide 3-kinase; PLC, phospholipase C; RGS, regulator of G protein signaling.
III. Molecular Basis for G Protein Activation
The rate-limiting step in G protein activation is the release of GDP from the nucleotide-binding pocket. GDP is spontaneously released from the heterotrimeric G protein at a rate that varies depending on the G␣-subunit. For example, the G␣ o GDP release rate (k off ) is 0.19 min Ϫ1 whereas the G␣ i2 release rate is 0.072 min Ϫ1 (11). However, the inactive state of the G␣-subunits is controlled by G␤␥ binding. Higashijima et al. (12) showed that in the absence of Mg 2ϩ , G␤␥ increases the affinity of G␣ o for GDP about 300-fold. GDP release is greatly facilitated by receptor activation of the G protein (13). Mutations (14 -16) of residues in the critical TCAT guanine nucleotide-binding motif present in the ␤6-␣5 loop of the GTPase domain (4) enhance receptor-independent spontaneous GDP release. Iiri et al. (14) identified such an activating mutation in G␣ s (A 366 S) in male patients with pseudohypoparathyroidism and gonadotropin-independent precocious puberty. Enhanced GDP release was also observed when similar mutations were generated in G␣ i [ 1 . Receptor-mediated G protein activation. The interaction of an endogenous ligand with its cell surface receptor (R) facilitates the coupling of the activate receptor (R*) with intracellular heterotrimeric G proteins. The R*-G protein coupling promotes the exchange of GDP for GTP on the G␣-subunit. G␣-GTP then dissociates from G␤␥ and R*. Both subunits are free to modulate the activity of a wide variety of intracellular effectors. Termination of the signal occurs when the ␥-phosphate of GTP is removed by the intrinsic GTPase activity of the G␣-subunit, leaving GDP in the nucleotide binding pocket on G␣. G␣-GDP then reassociates with G␤␥ and the cycle is complete. RGS proteins accelerate the intrinsic GTPase activity of G␣-subunits, thereby reducing the duration of signaling events.
mon mediator of GDP release. Posner et al. (15) also demonstrated that GDP release can occur without inducing a large conformational change in G␣. In addition to the TCAT motif, most recent work has identified residues within the helical domain as well as within the N-and C-terminal domains of G␣-subunits that are also integral mediators of spontaneous GDP release. For example, in G␣ t mutation of three residues located in the inward-facing surface of the ␣5-helix causes a dramatic increase of basal nucleotide exchange rate in addition to enhanced receptor-catalyzed nucleotide exhange rate (17). Mutation of five residues within the switch IV helical domain in G␣ s decreases the rate of GDP release, GTP␥S binding, and GTP hydrolysis (18) and disruption of contacts between the helical and GTPase domains also influences basal GDP dissociation rates (19, 20) . By fluorescently labeling the Cterminal residue Cys 347 of a G␣ t /G␣ i chimera, Yang et al. (21) determined that the C terminus moves into a more hydrophobic environment upon AlF 4 Ϫ activation. The authors suggest that this movement may reflect an interaction between the C terminus and the ␣2-␤4 loop of G␣ t /G␣ i . In addition, these divergent terminal domains have been implicated as the source of variation in the intrinsic GDP release rates among G␣-subunits. Substitution of 31 N-terminal residues of a G␣ t/i chimera (low intrinsic exchange rate) with corresponding 42 residues of G␣ s (high intrinsic exchange rate) significantly enhanced the nucleotide exchange rate (22). This same group also reported that disruption of a specific contact between Val 30 (N terminus) and Ile 339 (C terminus) alters the rate of GTP␥S binding, which was inferred as an indirect index of GDP release. Hence, structural interactions between N and C termini of G␣ t are important to the maintenance of a slow GDP release rate for G␣ t .
Receptor-mediated GDP release is dependent on the ability of the receptor to interact with the G protein and trigger conformational changes in G␣ that cause release of GDP. Comparing the crystal structure with biochemical data, we can deduce that the receptor contacts G␣ at a site that is more than 20 Å away from the guanine nucleotide binding site (1, 21) , thus working at a distance to release GDP. Current theory is that receptor contact with the C terminus of the G␣-subunit leads to conformational changes that are propagated through G␣ to the GDP binding site (1, 21) . However, the requirement for G␤␥ in receptor-G protein interaction and G protein activation suggests that G␤␥ may actively participate in GDP release by opening an exit route for the guanine nucleotide to leave the complex (23). The heterotrimer contains a prominent cavity between G␣ and G␤␥ that is believed to be oriented toward the plasma membrane (7, 24) . Activated loops of the receptor might use this cavity to tilt G␤␥ away from G␣ causing the contacts between G␣ and G␤␥ to be disrupted, including contacts near switch I and the ␤3-␣2 loop in G␣, the potential exit route for the nucleotide. In this way the receptor could use G␤␥ as a lever to release GDP (25). Ala substitutions in G␤ at the G␣-G␤␥ interface near the GDP exit route inhibit receptor-induced GDP/GTP exchange without affecting G␣-G␤␥ binding (26). Thus, the G␤␥-dimer is not merely a passive binding partner with the sole purpose of stabilizing G␣ but, rather, G␤␥ actively participates in receptor-mediated G protein activation.
IV. Structural Determinants of Receptor-G Protein Specificity
For the purposes of this review, we will limit ourselves to a discussion of regions within G␣ and G␤␥ that have been determined to mediate receptor-G protein specificity. For a thorough review of specific sites on heptahelical receptors, which direct receptor-G protein coupling specificity, the reader is referred to Refs. 27 and 28 for reviews. The extreme C terminus of G␣ (in particular the last five residues) has been established as an important mediator of receptor-G protein interaction (23, 29 -31). For example, ADP ribosylation of residue Ϫ4 by pertussis toxin uncouples G i /G o proteins from receptors (32). Phosphorylation of a tyrosine residue at Ϫ4 in G q/11 was shown to be required for coupling to metabotropic glutamate receptors (33) although this has not been demonstrated in intact cells. In addition, the requirement of phosphorylation at the tyrosine residue of G q/11 cannot be generalized as M 1 muscarinic receptors, and thrombin receptors were shown to couple readily to G q/11 proteins in reconstitution experiments (34, 35). Many examples of mutations in this region that alter receptor-G protein specificity have been also reported (36 -38). In addition, several investigators have generated sequence-specific C-terminal peptides or antibodies targeting the C-terminal domain to study receptor-G protein interaction. Antibodies recognizing G␣ C-terminal domains block receptor-G protein signaling (39). Instead, sequence-specific C-terminal synthetic peptides either stabilize the active agonist-bound form of the The C terminus is not the only region directing receptor-G protein interactions. Several G␣-subunits possess identical or nearly identical residues within the extreme C-terminal domain yet exhibit differential coupling to receptors. For example, within the last 11 amino acids of G␣ i1 and G␣ t , only a single residue is divergent, yet the serotonin IB receptor fails to couple to G␣ t and readily couples to G␣ i . Investigation into the molecular determinants of this specificity indicated that two residues within the ␣4-helix of G␣ i1 are critical mediators of this receptor-G protein coupling profile (44, 45). Key residues for coupling specificity have been also identified within the N terminus (36, 39, 46), the ␣2-helix, and ␣2-␤4 loop regions (47, 48) as well as within the ␣4-helix and ␣4-␤6 loop domain (44, 48, 49). Segments of G␤-and G␥-subunits may also contribute to the receptor interacting surface of heterotrimers (46, 50 -53). Using a peptide specific for ␣-helical residues in G␣ s , Krieger-Brauer et al. (54) blocked ␤-adrenergic receptor-mediated activation of both G␣ s -and G␤␥-effectors. In contrast, a C-terminal sequence-specific peptide for G␣ s only prevented G␣ s -mediated effector activation, suggesting that the extreme C terminus of G␣ s is required for G␣-mediated signaling but is not critical for ␤-adrenergic receptor recognition and dissociation of G␣ from G␤␥ (54). Together, these studies suggest that the relative importance of the C terminus for directing receptor-G protein interactions may be dependent on G␣ and receptor subtypes. Receptor-G protein specificity is clearly not mediated solely by one structural feature of G␣-subunits but appears to result from a network of specific contacts between the receptor and G protein which differs for each G␣-subunit and for each receptor and results in a large number of possible combinations that can bring remarkable specificity into a system with only a few central players. As suggested by Blahos et al. (36) , one of the difficulties in isolating the specific determinants of receptor-G protein coupling has been that G protein coupling may still occur even when interactions at certain contact points are weak, absent, or negative if these frailties can be overcome by a stronger interaction at other contact points or when regions that may weaken coupling are removed from either the receptor or the G protein.
V. Receptor-Independent Activators of G Protein Signaling (AGS Proteins)
A novel class of signaling proteins, termed AGS proteins, has been identified (55, 56). AGS proteins activate heterotrimeric G proteins independently of receptor activation. The mechanism for AGS activation differs among members of this family. AGS1 has been found experimentally to promote GTP␥S binding. AGS2 selectively associates with G␤␥, whereas AGS3 binds to G␣ and exhibits a preference for GDP-G␣ vs. GTP-G␣. AGS3 has been shown to prevent the reassociation of G␤␥ with the G␣-subunit and function as a guanine dissociation inhibitor for G␣ i -subunits (57). AGS3 contains a G protein-regulatory motif. This G protein regulatory motif or GoLOCO repeat is an approximately 20-amino acid domain found in several proteins that interact with and/or regulate G proteins, e.g., AGS3, the Partner of Inscuteable and its mammalian homolog, LGN, Purkinje cell protein 2, and Rap1 GTPase-activating protein (GAP). The physiological role of these proteins in vivo remains to be determined, but one possible role for these proteins may be in the regulation of G proteins that do not reside near the plasma membrane and cannot be activated directly by receptors, e.g., G proteins in the Golgi that regulate vesicular trafficking (58). Little is known about the role of this pool of G proteins, and the discovery of AGS proteins may stimulate research into a new dimension of heterotrimeric G protein signaling.
VI. The Receptor-G␣ Protein Interface as a Therapeutic Target
Traditionally, the extracellular surface and transmembrane domains of G protein-coupled receptors have served as a target for the development of drugs that can selectively activate or inactivate specific cellular pathways. However, some receptor isoforms, such as the dopamine D 2L and D 2S receptors, and the D 4 receptor variants differ only on the intracellular surface of the protein (59, 60) and cannot be readily distinguished by targeting the ligand-binding site. Moreover, many receptors promiscuously couple to several G protein subtypes in what may be a tissue-or cell-specific phenomenon. Therefore, additional therapeutic targets will certainly be required to more specifically influence intracellular signaling events. One avenue being explored by our laboratory and others is the use of peptide inhibitors that target the receptor-G protein interface (43, 61, 62). Currently, these peptides represent either G␣ C-terminal-specific sequences or peptides isolated from a combinatorial library based on C-terminal G␣-sequences and screened for highaffinity receptor binding (31). These studies are based on the idea that the C terminus of G␣-subunits serves as a key receptor contact site and mediator of receptor-G protein specificity. In the short term, these peptides may provide useful tools for exploring specificity of G protein-mediated signaling.
The delivery of peptide inhibitors represents a challenge to the therapeutic use of these tools. Possible delivery (gray); G␥ (pink). The area on G␤ that is covered by G␣ in the G protein heterotrimer crystal structure is highlighted in light green. The effector-interacting residues on G␤ are circled with colored dashed lines as follows: ␤-adrenergic receptor kinase (orange); PLC␤ 2 (red); AC II (green); K ϩ channel (blue); Ca 2ϩ channel (yellow). G␣-GDP, when bound to G␤␥, covers all these distinct yet partially overlapping effector interaction regions on G␤ and, thus, blocks G␤␥ regulation of all the effectors. [ Figure 2C systems include the use of inducible retroviral minigene vectors (64), incorporation of peptides into liposomes (65), or the fusion of peptides to a viral peptide sequence that carries the C-terminal peptide into the cell (66). Alternatively, peptidomimetics may prove to be more stable and bioavailable. Selective targeting to specific organs is likely to prove beneficial, because Akhter et al. (67) have demonstrated that transgenic mice selectively expressing a Gq C-terminal minigene in the myocardium exhibit a marked inhibition of ␣ 1B -adrenergic receptor-mediated inositol phosphate production and blockade of cardiac hypertrophy. The identification of peptide inhibitors with high affinity for specific receptor subtypes and/or variants would also allow for more selective inhibition of signaling pathways. Despite the significant hurdles, targeting the receptor-G protein interface will clarify the complex coordination of players in signaling cascades and may prove therapeutically useful in the future.
VII. G␣ Interaction with Effectors
Once G␣-GTP has dissociated from the G␤␥-dimer, G␣ can directly interact with effector proteins to continue the signaling cascade. The specific effector proteins activated by G␣ are dependent on the G␣-subtype and are summarized in Table 1 . Well-defined G␣ effectors, such as adenylyl cyclase (AC) and phospholipase C (PLC), have been the topic of several excellent reviews (68, 69).
Overall, several patterns emerge upon examination of the G␣-effectors. First, each G␣-family activates a distinct profile of effectors. The molecular basis for this divergence has not been completely elucidated. Cocrystallization studies of G␣ s and the catalytic domains of AC have identified specific contacts within G␣ s at the ␣2-helix (SII) and the ␣3-␤5 loop (70). In addition, the ␣4-␤6 loop of G␣ s also plays a role in AC activation (71). Sunahara et al. (72) demonstrated that GDP-bound G␣ s can also stimulate AC, albeit with a lower potency than the GTP-bound ␣-subunit. These data are intriguing because they suggest that reassociation of G␣ with G␤␥ is required for the complete termination of G␣ s signaling, and inhibition of reassociation could prolong both G␣-and G␤␥-mediated signaling. In addition, G␤␥ could serve to prolong signaling because it can block the PLC␤-mediated acceleration of GTPase activity at G␣ q -proteins (73). Second, within a family, each G␣-subunit exhibits a differential profile of effector activation. For example, G␣ i2 is required to inhibit forskolin-stimulated AC activity whereas G␣ i3 serves to inhibit G␣ s -activated AC (74). In addition, ␣ 1 -adrenergic receptors elevate intracellular Ca 2ϩ by two distinct mechanisms that are dependent on the G␣-subunit coupled to the receptor: G␣ q releases Ca 2ϩ from the endoplasmic reticulum whereas G␣ 11 activates a nonselective cation channel (75). Third, some G␣-subunits have only one identified effector, such as cGMP phosphodiesterase for G␣ t whereas others more promiscuously couple to several effector proteins. Lastly, effectors for some G␣-subunits have yet to be definitively identified, and the search for novel G␣-effectors is a rapidly growing area of research. A number of proteins that directly interact with G␣-subunits have been identified, yet further evidence awaits as to whether guanine nucleotide binding to G␣ regulates the activity of these proteins in vivo in response to receptor activation. Nonetheless, some of the most recent studies identifying novel putative G␣-effectors are discussed below.
Using a yeast-two-hybrid screen, Jordan et al. (76) identified direct interactions between G␣ o and Rap1 GAP, Gz GAP, and RGS17. This group also determined that Rap1 GAP interacts with G␣ i -proteins but not with G␣ q or G␣ s . However, receptor-mediated activation of these proteins was not demonstrated. Interestingly, Rap1 GAP interacted preferentially with GDP-bound G␣ o , suggesting that G␣ o -GDP may sequester Rap1 GAP away from Rap1, resulting in a sustained activation of MAPK. These findings reveal a novel mechanism of G protein function that is dependent on GDP-liganded G proteins. G␤␥-subunits might then be considered as inhibitors of G␣-GDP proteins (and vice versa).
In search of G␣ z -effectors, Chen et al. (77) screened a cDNA expression library using phosphorylated G␣ z -GTP␥S as a probe. This group identified two proteins that interact with G␣ z and named them GRIN1 and GRIN2 for G proteinregulated inducer of neurite outgrowth 1 and 2. Both GRIN1 and GRIN2 bound to activated G proteins (G␣ o , G␣ i , and G␣ z ) and were identified in neural tissue, but the regulatory mechanism for neurite growth is unknown.
The Ca 2ϩ binding protein calnuc (nucleobindin) is a potential effector for G␣ i3 and G␣ s (78, 79) . The binding of calnuc to G␣ i3 has been shown to be Ca 2ϩ and Mg 2ϩ dependent (80) . This ion dependence has not been shown explicitly for G␣ s , probably because calnuc undergoes a conformational change after Ca 2ϩ binding (81) that could be necessary for G protein interaction.
Bruton's tyrosine kinase (Btk) has been identified as a novel effector for G␣ q proteins because G␣ q activates Btk both in vitro and in vivo, and this activation is required for receptor-mediated stimulation of p38 MAPK (82) . However, the generalization of these results to other G q family members remains to be determined.
Although a role for G␣ 12/13 -proteins had been established in several physiological events such as stress fiber formation, cellular transformation, regulation of Na ϩ /H ϩ exchange, modulation of inducible nitric oxide synthase expression, and regulation of Erk and c-jun kinase activity (83) , direct interaction of G␣ 12/13 with effector proteins has been established recently, when Hart et al. (84) identified p115RhoGEF as a direct effector for G␣ 13 . A RGS protein, p115RhoGEF, is also shown to serve as a GAP for both G␣ 12 and G␣ 13 . However, only activated G␣ 13 is able to stimulate p115RhoGEF to trigger GDP/GTP exchange on the small molecular weight G protein Rho. In addition, the cytoskeletal-associated protein radixin has been found to interact with G␣ 13 (85) whereas an interaction between G␣ 12 and heatshock protein 90 is required for G␣ 12 -induced serum response element activation, cytoskeletal changes, and mitogenic response (86) .
VIII. G␤␥ Interaction with Effectors
Initially, G␤␥ was thought to facilitate the completion of intracellular information transfer passively by binding to G␣ and hastening the return of the heterotrimer to the plasma membrane, thereby preventing noise or spontaneous G␣ activation in the absence of receptor stimulation (87) . This belief changed when G␤␥ was shown to activate a K ϩ -selective ion channel (I KACh ) in cardiac atrial cells (88 (102) . Conversely, G␤ and G␥ combinations that were excluded in in vitro assays (104) display functional effects when transfected into cells (108) . Although G␤␥-dimers of varying composition may form in vivo as well, G␤␥-dimer combinations may also exhibit cell type or tissue specificity. For example, in the retina the primary G␤␥-dimer is G␤ 1 ␥ 1 whereas G␤ 1 ␥ 2 is the most common dimer formed in the brain (109, 110) .
A. G␤␥-Dimer composition directs effector and receptor coupling
What is the physiological significance of the formation of different G␤␥-dimers? Although it was previously thought that G␤␥-dimers were for the most part interchangeable, current research indicates that G␤␥-dimer composition determines the quality and efficiency of effector activation and may mediate receptor-G protein coupling specificity similar to G␣-subunits. For example, when nine unique dimers of G␤ 1 or G␤ 2 with G␥ (1, 2, 3, 5 or 7) were tested for the ability to activate various PLC␤ isoforms, all dimers could activate the various PLC␤ isoforms except retinal-specific G␤ 1 ␥ 1 (111, 112) . Likewise, G␤ 1 ␥ 1 was markedly less effective at stimulation of ACII and inhibition of ACI than other G␤␥ dimer combinations (111, 112) . A comparison of G␤ 1 ␥ 2 with G␤ 5 ␥ 2 demonstrated that G␤ 5 ␥ 2 is a much weaker inhibitor of ACI, ACV, and ACVI. In addition, G␤ 1 ␥ 2 stimulated ACII activity, whereas G␤ 5 ␥ 2 inhibited the activity of this enzyme (113) . In contrast, both G␤ 1 ␥ 2 and G␤ 5 ␥ 2 activated PLC␤ 2 with similar potency and efficacy (114) . Finally, the rank order for G␤-subtype inhibition of voltage-dependent N-type Ca 2ϩ currents differs from enzyme activation [G␤ 1 ϭ G␤ 2 Ͼ G␤ 5 Ͼ ϾG␤ 3 ϭ G␤ 4 ; (115)], and this potency difference may be related to the ability of the various G␤-subunits to physically interact with the L I-II loop of the Ca 2ϩ channel (115) . Together, these data demonstrate that the primary sequence of the G␤-subunit is a major determinant of effector coupling efficiency and specificity. Isolation of the structural features responsible for effector variation remains to be completely determined. Recently, Mirshahi et al. (116) have shown that Ser 67 in G␤ 1 is part of a functional domain that regulates several different effectors whereas other residues of the ␤-propeller seem to direct the effector specificity.
With respect to receptor-G protein coupling specificity, both G␤ 1 ␥ 2 and G␤ 5 ␥ 2 can couple G␣ q -proteins to endothelin B and M 1 muscarinic receptors. However, G␤ 1 ␥ 2 but not G␤ 5 ␥ 2 promotes endothelin B receptor-G␣ i -protein interaction (107) . Thus, the G␤ 5 ␥ 2 -dimer specifically couples G␣ qproteins to receptors (117) . With the exception of G␤ 5 , the identity of the G␤-subunit does not currently appear to be a critical determinant of receptor-G protein specificity. For example, A 1 adenosine receptors couple equally well to G␣ iproteins containing G␤ 1 ␥ 2 -, G␤ 1 ␥ 3 -, G␤ 2 ␥ 2 -, or G␤ 2 ␥ 3 -dimers as measured by reconstitution of high-affinity agonist binding (118) . In contrast, G proteins containing a farnesylated ␥-subunit coupled less efficiently to the A 1 receptor, suggesting that lipid modification of the G␤␥-dimer can influence receptor-G protein coupling efficiency (52).
B. Structural determinants of effector specificity
Unlike G␣-subunits, the conformation of G␤␥-dimers does not significantly change whether G␤␥ is in the inactive heterotrimeric complex or in the free active state. One notable exception to this idea is that phosducin binding to G␤␥ induces a conformational change primarily in blades 1 and 7, thus preventing G␤␥ association with additional effectors (119) . Once dissociated from G␣, G␤␥ can interact with a number of effectors. Using alanine scanning mutagenesis, our laboratory (26) and others (120, 121) previously identified residues on G␤ that contact G␣ and that mediate a number of effector interactions including ion channels, PLC␤ 2 , and ACII (Fig. 2C) . Regions important for ACII interaction map roughly to blades 2, 3, and 5, whereas the Nterminal interface of G␤ interacts with G protein-activated, inwardly rectifying potassium channels, 1 and 4 (26). In addition, point mutations either on the G␣ interacting face of (121) . Therefore, each effector contacts a unique but overlapping set of residues on G␤, and some of these sites also represent G␣ interacting sites. These studies are consistent with the idea that interaction with ␣ precludes G␤␥ binding to effector proteins. Mutational studies continue to reveal the molecular basis for effector interaction as well as the structural basis for variations between G␤␥-subunits in effector coupling efficiency. However, one key question yet to be resolved is how G␤␥ activates a particular effector once freed from G␣, in a cytoplasmic milieu full of potential partners. Signaling specificity could be brought about by factors such as discrete subcellular localization of effectors, compartmentalization of scaffolding components, and cell type-specific expression of signaling molecules (122) . The formation of signaling networks that bring together specific receptors, G proteins, regulatory proteins, enzymes, and substrates is a hot area of research and will likely reveal key factors regulating signaling specificity.
C. Novel G␤␥-effectors
At the current discovery rate of G␤␥-effectors, the final tally of proteins that interact with the G␤␥-dimer is likely to exceed that for G␣-subunits (68). As shown in Tables 1 and  2 , G␤␥-and G␣-subunits interact with a number of common effectors, such as PLC␤, Bruton's tyrosine kinase, and certain types of ACs. These effector interactions can be independent, synergistic, or antagonistic. For example, G␤␥-subunits potentiate ACII activation by G␣ s , but inhibit G␣ s -stimulated ACI activity. In addition, G␤␥-dimers interact with a number of novel effectors that are not regulated by G␣-subunits. These novel effector interactions expand the role of G proteins in the regulation of various cellular processes and are briefly discussed below.
Putative G␤␥-effectors recently identified include protein kinase D (123), PI 3 kinase (93, 94) , tubulin (124), KSR-1 (125), dynamin I (126), Raf-1 protein kinase (127), Tsk protein kinase (128) , and calmodulin (129) (see Table 2 and references therein). Although previous data suggest that G␤␥-effectors bind to an overlapping domain on G␤-subunits, additional studies also indicate that G␤␥ binding to one particular effector does not necessarily preclude G␤␥ interaction with a second effector protein. For instance, G␤␥ binding to calmodulin does not prevent G␤␥-mediated stimulation of PLC␤ (129) . The ability of G␤␥ to simultaneously regulate different effectors suggests that the G␤␥ conformation is not disturbed upon effector binding. One notable exception to this idea is that phosducin binding to G␤␥ induces a conformational change primarily in blades 1 and 7 preventing G␤␥ association with additional effectors (119) . Likewise, G␤␥ interaction with the protein kinase KSR-1 prevents G␤␥-mediated stimulation of MAPK (125) . However, the mechanism responsible for this exclusivity remains to be elucidated. As mentioned before, Chidiac and Ross (73) showed that G␤␥ could prevent the acceleration of the GTPase activity of G␣ q by PLC␤, which implies a dual role for G␤␥ because it can stimulate PLC␤ activity directly and indirectly (through prolonged activation of G␣ q ).
Although most G␤␥-effectors are believed to directly interact with the G␤-subunit, a role for the G␥-subunit has also been suggested. Using a yeast-two-hybrid screen with the protein kinase KSR-1, Bell et al. (125) identified G␥ 2 , G␥ 3 , and G␥ 10 as interacting proteins. The C terminus of G␥-subunit seems to play a direct role in modulating PLC␤ functions (130) 
D. Additional role for G␤ 5
G␤ 1-4 share 80%-90% sequence homology and are ubiquitously expressed (133) . In contrast, G␤ 5 shares only about 50% identity with the others and is preferentially expressed in the central nervous system (134) . G␤ [1] [2] [3] [4] are entirely particulate proteins, whereas G␤ 5 can exist both in the soluble and membrane fractions (134) , and the N-terminal domain of G␤ 5 is significantly longer than the other G␤-subunits. Although this region is important for G␥ interaction (135), G␤ 5 can dimerize with G␥, form functional heterotrimers with G␣, and interact with a number of effectors in response to receptor activation (102, 113, 114, 117, 134) . However, unlike other G␤-subunits, G␤ 5 can readily dissociate from G␥ under low-stringency conditions and is stable in solution without being complexed to G␥ (136, 137) . Free G␤ 5 has been shown to interact with certain GAPs known as regulators of G protein signaling (RGS proteins) through a G protein G␥-subunit-like domain (138, 139) . The G protein G␥-subunitlike domain is a 64-amino acid region (34% identical to G␥ 5 ) that is present in RGS6, RGS7, RGS9, RGS11, and the Caenorhabditis elegans RGS protein EGL-10 (140). G␤ 5 binding to RGS proteins enhances the ability of the proteins to accelerate the GTPase activity of G␣-subunits (141) . In addition, G␤ 5 binding to RGS6, -7, and -11 allows for the selective inactivation of G␣ o (140) and may localize these RGS proteins within the cytosolic compartment (142) . Is G␤ 5 always associated with an RGS protein in vivo, or does it shuttle between RGS proteins and G␥-subunits? In native preparations, RGS9 exists in a tight complex with the long splice variant of G␤ 5 (G␤ 5Long ) in vertebrate photoreceptors (138) . The G␤ 5L -variant was absent from the retinal tissue of RGS9-deficient mice despite the presence of normal levels of G␤ 5 mRNA (143) . In contrast, G␤ 5Short protein levels were normal in knockout mice. Therefore, RGS9 may be required for the translation or stability of G␤ 5L in photoreceptor cells whereas G␤ 5S may be free to interact with G␥-subunits (143) . Other questions yet to be resolved include: does G␤ 5 interact with other proteins outside the RGS family? Do free G␥-subunits have a signaling role on their own? What is the brain-specific role for G␤ 5 ? The discovery of G␤ 5 independent of G␥ has clearly disproved the previous dogma that G␤-subunits associate only with G␥, and that only through this association do they elicit a physiological response.
IX. Molecular Basis for G Protein Inactivation

A. Intrinsic GTPase activity
As previously mentioned, the duration of G protein-mediated effector activation is dependent on the intrinsic GTPase activity of the G␣-subunit. Like the intrinsic GDP release rates, intrinsic GTP hydrolysis activity varies among G␣-subunits (83) . For example, the catalytic rate constant value for GTP hydrolysis for G␣ z is approximately 200-fold lower than that of G␣ s and G␣ o (83, 144, 145) . The GTPase domain is highly homologous among G␣-subunits and the side chain of a conserved arginine residue (Arg 174 in G␣ t ; located within the helical domain) forms hydrogen bonds with oxygens of the ␣-and ␥-phosphates and the ␤-␥ phosphate bridging oxygen. This Arg residue plays a key role in GTP hydrolysis. Thus, mutations of either this Arg or residues contacting it have been reported to alter the GTPase activity of G␣-subunits (2, 146) . Because of the conserved nature of the GTPase domain of G␣-subunits, the determinants of G␣-hydrolysis variability are likely to lie in the divergent helical domain and within the N and C termini or be the result of subtle flexibility and conformational changes among G␣-subunits. The mechanisms responsible for variations in GTP hydrolysis rates have not been studied in detail. Research in this area has focused instead on identifying proteins that directly interact with G␣-subunits to regulate their intrinsic GTPase activity. Some of these key studies are discussed below. For the interested reader, detailed descriptions of the mechanism of GTP hydrolysis can be found elsewhere (2, 9).
B. G␣ Interaction with GTPase-activating proteins (GAPs)
Several years ago, researchers noted that the intrinsic GTPase activity of G␣-subunits occurs in vitro at a much slower rate than can account for the observed deactivation rates of G protein-controlled processes (147, 148) . Therefore, speculation mounted that, in vivo, an additional protein was rapidly terminating signal transduction, returning the system to an agonist-responsive state. In mammals, the G␣-effectors PLC␤ and the ␥-subunit of phosphodiesterase (P␥) were two of the earliest identified GAPs for G␣ q and G␣ t , respectively (149 -151) . Most recently, Scholich et al. (152) have determined that the effector ACV serves as a GAP for G␣ s . Thus, after activation by G␣, an effector can feed back on the activated G␣-subunit and significantly reduce the duration and amplitude of the signal generated.
In addition to effector-mediated feedback inhibition, RGS proteins enhance the GTPase activity of G␣-subunits, thereby reducing the duration and amplitude of both G␣-and G␤␥-mediated cellular responses (153) (154) (155) (156) . RGS proteins share a common approximately 125-amino acid domain termed the RGS box (157, 158). To date, more than 30 mammalian RGS proteins have been identified (156, 158 -160) , each containing 23 conserved hydrophobic residues at the core of the RGS domain (155, 156, 159, 161) . In vitro, the RGS core domain is both necessary and sufficient for GAP activity. However, in vivo this is not the case. Our laboratory and others (162, 163) have demonstrated that in native retinal preparations, RGS9 requires effector activation for the full expression of RGS GAP activity. Likewise, the core RGS domain of RGS16 can stimulate G␣ o GTP hydrolysis in vitro but requires additional N-terminal residues for functional activity in vivo (164) . These studies suggest that in vivo the noncatalytic domains regulate RGS GAP activity through interactions with cellular factors. Only two such factors have been identified to date, G␤ 5 and phosphodiesterase E␥ (141, 151, 165) . Noncatalytic domains of RGS proteins have also been suggested to mediate signal transduction pathway specificity and subcellular targeting of RGS proteins (154, 166) .
GAPs for heterotrimeric G proteins accelerate GTP hydrolysis in a manner that differs from that observed with monomeric G protein GAPs. For example, Ras GAP inserts a catalytic Arg residue into the active site that participates in the hydrolysis step (2). However, this Arg finger is provided by the helical domain in heterotrimeric G proteins and mediates intrinsic GTP hydrolysis as discussed above (2) . In contrast, RGS proteins bind to the switch regions on G␣ and thereby stabilize the G␣ transition state toward GTP hydrolysis (167) . The mechanism for effector-mediated GAP activity has not been clearly delineated. By analogy, effectormediated GAP activity may also occur through a similar stabilizing mechanism. However, differences in activity between effector GAPs and RGS GAPs have been observed. For example, Mukhopadhyay and Ross (168) demonstrated that RGS4 produces a 2-fold greater acceleration of the G␣ qbound GTP hydrolysis rate in comparison to PLC␤, but PLC␤ is 100 times more potent than RGS4. Although these findings might suggest different mechanisms of GAP activity for effectors and RGS GAPs, G␤␥ can inhibit the GAP activity of both PLC␤ 1 and RGS4 (73) . This is consistent with the idea that G␤␥, effectors, and RGS proteins bind to the same region on G␣, namely the switch regions of the GTPase domain. Thus, RGS proteins can act as effector inhibitors as well as GAPs. On the other hand, we and others recently determined that the effector P␥ enhances the GAP activity of the regulator of G protein signaling 9 (RGS9) core domain by increasing the affinity of the RGS9 domain for a G␣ t/i chimera (163, 170) . These studies suggest that RGS proteins may be regulated through their participation in a signal transduction complex that may include receptors and effectors and may be localized near the plasma membrane. A similar suggestion was proposed by Chidiac and Ross (73). Our laboratory has also determined that the ␣-helical domain of G␣ t (a G␣ i family member) is a key molecular determinant of the selectivity that the RGS9 core displays as a GAP for G␣ t vs. G␣ i (163) . Therefore, RGS protein affinity and GAP activity for various G␣-subunits may be mediated, at least in part, by the primary structure of the G␣-subunit as well as by the sequence of the RGS box. Further in-depth discussion of RGS proteins can be found in one of several reviews on this topic (154 -156, 161, 166 ).
X. Regulation of G Protein Function by Covalent Modification
G protein signaling cascades are also regulated by posttranslational modification of the G proteins themselves, which includes phosphorylation and/or acylation of G␣-and G␤␥-subunits. Phosphorylation of G␣-subunits by protein kinase C inhibits signal transduction through G␣ i family members (171) (172) (173) (174) . For G␣ z , stoichiometric phosphorylation occurs at N-terminal Ser 16 and G␣ z -GDP is the preferred substrate (175, 176) . Protein kinase C phosphorylation of G␣ z prevents heterotrimer formation (175) and inhibits GAP activity of RGSZ1 (177) . Thus, phosphorylation could significantly prolong G␤␥-effector activation while reducing G␣-effector stimulation. The GDP-bound forms of G␣ t and G␣ s are also kinase substrates (178, 179) , and phosphorylation of G␣ 12 prevents interaction with G␤␥ (180) . Phosphorylation of G␤- (181) and G␥-subunits has also been reported (182) , and phosphorylation of G␤ 1 ␥ 12 inhibits G␤␥-mediated AC activation without altering the activation of PLC␤ (183) . Thus, phosphorylation cannot only dissociate G␣-and G␤␥-mediated signaling, but it also regulates the selective modulation of particular G␤␥-effectors.
A. G protein lipidation
In addition to phosphorylation, G␣-subunits are lipidated (myristoylated and palmitoylated) at their N termini. Nmyristoylation results from cotranslational addition of the saturated 14-carbon fatty acid myristate to a Gly residue at the second position after the removal of the initiating Met by the enzyme methionine amino-peptidase (184) . A stable amide bond links the myristate to the protein. Hence, this myristoylation is essentially an irreversible modification. Only G␣-subunits of G i family are myristoylated (see Refs. 174 and 185-187 for review). In addition, all G protein G␣-subunits, except G␣ t , contain the posttranslationally attached saturated 16-carbon fatty acid palmitate and some G␣-subunits (G␣ q , G␣ 11 , G␣ 13 , and G␣ 16 ) are palmitoylated at multiple sites (see Refs. 174, 188 , and 189 for review). Palmitoylation of proteins results from the esterification of Cys thiol groups by palmitate. Due to its unstable character, palmitoylation is readily reversible and subject to regulation (188, 190) . As yet, palmitoylation cannot be accurately predicted based on primary sequence. However, palmitoylation occurs frequently in proximity to other lipid modifications such as myristoylation or prenylation.
The G␥-subunit when dimerized with G␤ is isoprenylated posttranslationally. The 15-carbon isoprenoid farnesyl (G␥ 1 , G␥ 8 , and G␥ 11 ) or the 20-carbon isoprenoid geranylgeranyl (other G␥-subunits) is attached via a stable thioether bond to a Cys residue located in the C-terminal CAAX box of G␥, followed by the proteolytic removal of the C-terminal three amino acids and then the carboxyl methylation of the new C terminus (191) . The X residue in the CAAX motif is a major determinant of the isoprenyl group. If X is a Ser, Met, Gln, or Ala, the proteins are farnesylated, whereas Leu at this position results in geranylgeranylation (see Ref. 192 for review). Carboxymethylation of the C terminus of G␥ appears to modulate the affinity of the membrane attachment (193) .
B. The role of lipid modifications in G protein membrane association and consequent signaling functions
One clear function of fatty acid acylation is to serve as a hydrophobic membrane anchor. For the G i family of G␣-subunits that are both myristoylated and palmitoylated, both modifications contribute to the membrane association. Removal of the palmitoylation site while preserving myristoylation results in a partial shift in localization from the membrane to the cytoplasm (194 -197) . Likewise, mutation of the N-terminal Gly on G␣, which abolishes myristoylation, also inhibits palmitoylation and similarly shifts protein localization (184, 198, 199) . Shahinian and Silvius (200) have recently proposed a "kinetic membrane trapping" model for G proteins to account for this localization dependence on both lipid modifications. Within this two-signal model of membrane binding, myristoylation and palmitoylation cooperate to target G␣ i -subunits to the plasma membrane. Myristoylation serves as the initial signal bringing the protein to the membrane, and palmitoylation is the second signal that further secures this interaction. In addition, palmitoylation may specifically target G proteins to the plasma membrane rather than to intracellular organelle membranes (174, 195, 201) . Consistent with this two-signal model, in the case of myristoylation-defective mutants of G␣ z and G␣ o , the prenylated G␤␥-subunit can substitute for myristoylation and carry the ␣-subunit to the plasma membrane where it can be palmitoylated and fulfill its signaling activity (174, 202) .
For G␣-subunits that are modified solely by palmitate (G␣ s , G␣ q , G␣ 12 , and G␣ 13 ), mutations that prevent palmitoylation markedly impair membrane association (203) (204) (205) (206) . In addition, G␤␥ appears to be a crucial prerequisite for membrane anchoring and palmitoylation of G␣ s and G␣ q (207) . However, by enzymatically depalmitoylating G␣ q , Hepler et al. (208) have determined that Cys residues rather than palmitoylation per se are critical determinants of G␣ q -mediated signal transduction. Because most studies investigating the role of palmitoylation have relied on mutating Cys residues, further studies are needed to determine whether the significance of palmitoylation itself has been overestimated thus far. Indeed, a paper by Fishburn et al. (209) used a mutant G␤␥ complex, which mislocalized to the mitochondrial membrane, to investigate the relative contributions of protein-protein interactions vs. lipid modifications in controlling membrane targeting of G␣ z . Using this approach, these authors determined that G␣ z interaction with G␤␥, rather than palmitate, directs specific targeting of G protein G␣-subunits to membranes.
Lipid modifications also regulate protein-protein interactions. For example, N-myristoylation of G␣ modulates G␤␥ (210) and effector interactions (211) , and palmitoylation increases the affinity of G␣ s for G␤␥ (212) . In addition, palmitoylated G␣ s ␤␥ is more resistant to thioesterase cleavage of palmitate than free palmitoylated G␣ s (212) . Palmitoylation can also inhibit the interaction of GzGAP (an RGS protein) with G␣ z (213) . Thus, the palmitoylation state of G proteins can affect their ability to serve as signaling molecules. As part of a feedback mechanism, palmitate turnover can also be regulated by receptor activity (196, 214) .
The addition of the prenyl group to the G␥-subunit plays a central role in the membrane association of the G␤␥ complex (for review see Ref. 215 ). Although not required for G␤␥-dimer formation, isoprenylation of G␥ is necessary for productive interaction of G␤␥ with other proteins including G␣ (111) and effectors such as AC (216 -218) , PLC (217, 218) , and PI 3 kinase (217, 219, 220) as well as with receptors (52).
XI. Advances for the Future: Investigating the Dynamic Nature of G Protein Signaling
The resolution of crystal structures for active, inactive, transition state of G␣ (3-6) has provided a basis for understanding G proteins as molecular switches for signaling pathways. These studies also provide a framework for conducting structural, functional, and biochemical experiments that can extend our understanding of G proteins along with their various signaling partners. Because only a few G proteins have been crystallized to date (see Table 3 ), interpretations and conclusions from these structures may not reflect the full complexity of subunit combinations. Moreover, the static nature of such structures may actually limit our understanding of the dynamic nature of G protein signaling. To more accurately assess G protein interactions with receptors, effectors, and regulators of G protein signaling, it will be necessary to take advantage of new techniques that can provide insights into the complex nature of G protein activation. A few of these techniques are described below.
Fluorescence spectroscopic techniques continue to play an important role in determination of G protein conformational changes. In particular, fluorescence resonance energy transfer (221) provides a real-time measurement of activation, deactivation, and protein-protein interactions under basal and stimulated conditions. Fluorescence resonance energy transfer involves attachment of different fluorescent donor and acceptor probes at known residues. Changes in tertiary structure as a result of binding or activation, which result in the donor fluorophore coming into close proximity to the acceptor fluorophore, result in a quenching of donor emission and a simultaneous increase in acceptor emission as energy is transferred. This can be measured as a ratio between donor and acceptor emission in specific timed intervals, resulting in a real-time measurement of dynamic changes in protein conformation that is both sensitive and specific to labeled regions of the proteins. For example, Remmers (222) used a fluorescently labeled GTP␥S analog, N-methyl-3Ј-O-anthranoyl-GTP␥S, to measure conformational changes in heterotrimeric G proteins upon nucleotide binding. G protein intrinsic Trp fluorescence decreased whereas N-methyl-3Ј-O-anthranoyl-GTP␥S fluorescence increased upon binding the nucleotide analog. In conjunction with stopped-flow fluorescence measurements, the kinetics of the binding reaction can also be determined. Stopped-flow fluorescence itself has long been used to measure binding kinetics and has been used recently to measure GAP activity as a result of RGS proteins binding to activated G␣-subunits (223) .
Spin labeling can also be used to examine changes in protein conformation in real time. This technique requires introduction of a nitroxide side chain at specific residues and electron paramagnetic resonance signal from the nitroxide spin label can detect and report subtle changes in its local environment. It is possible to determine changes in solvent accessibility, dynamics, and intermolecular distances of side chains in solution in real time, yielding information about the time scale and magnitude of structural changes in the labeled region of the protein. Spin pairs can be used to determine changes in the secondary structure of proteins; introduction of spin labels at positions (i) and (i ϩ 4) allows examination of helical structure within proteins. Changes can be measured on a millisecond time scale. Farrens et al. (224) successfully employed this technique to determine movements of helices that accompany rhodopsin activation. They found that ␣-helix C of rhodopsin moves as a rigid unit in relation to ␣-helix F upon light activation of this receptor. This technique is being further used in studies to determine conformational changes in the N terminus of G␣ i upon activation, because these residues are absent or disordered in most high-resolution crystal structures of GDP-or GTP␥S-bound form of G␣-subunits (3, 4, 6) (see Table 3 ) with the exception of the G␣ i /RGS4 complex. In the crystal structure of RGS4 core domain bound to aluminum fluoride-activated G␣ i -GDP subunits, G␣ i makes two differing sets of contacts with the RGS molecule. One contact is through the G␣ i -switch region binding to the RGS core domain, whereas the second contact is through the N terminus of the G␣ i binding to an adjacent RGS molecule in the crystal. This suggests some type of crystallization artifact, leaving a question as to the relevance of the N terminus present in this 2.8-Å structure. Although it is clear from heterotrimeric structures that G␤␥ binding stabilizes an N-terminal ␣-helix in G␣-subunits, this may change upon activation. Indeed, site-directed spinlabeling studies have shown that G␣ i N terminus is dynamically disordered in the GDP-bound form, but adopts a structure consistent with an ␣-helix upon interaction with G␤␥ (225) . However, activation of the spin-labeled G␣ i ␤␥ complex by photoisomerized rhodopsin in the presence of GTP␥S causes the N-terminal domain of G␣ i to revert to a dynamically disordered state similar to that of the GDP-bound form (225) .
Another powerful technique for measuring proteinprotein interactions in real time is surface plasmon resonance. This technique measures changes in refractive index on the surface of a chemically modified sensor chip as a binding event occurs. The resultant binding curve allows for a quantitative measure of affinity of the binding interaction. Figler et al. (226) used this technique to determine the affinities of G␣-subunits for various G␤␥ combinations. Current (227) . Computational approaches such as structure prediction and three-dimensional modeling and mathematical techniques such as monte-carlo simulations all provide valuable insights into G protein signaling. More importantly, they are valuable tools that serve to direct further biochemical and functional experiments. These approaches, combined with genetics, can be used to define and examine key components of the signaling pathway, which will both broaden our understanding of the complex nature of G protein signaling and lead to new questions for further investigations.
Structural and functional aspects of heterotrimeric G proteins, their binding partners, and the signaling networks in which they participate are the subjects of intense investigation, and dramatic progress has been made in recent years. The next frontier is to understand how signaling pathways interact with each other to form signaling networks (241) . Cells are bombarded with a multiplicity of ligands, and the cellular response is somehow integrated based on all its responses. The experimental approaches to this problem are beginning to be available, but are in their infancy. Certainly, many new approaches to these issues of complexity in cellular signaling will need to be pioneered, and will surely lead to new insights. 
